Together, these results suggest <i>MSLN</i> protein is a potential target for antigen-specific therapy and supports investigation into its tumorigenic effects to identify possible therapeutic interventions for patients with high <i>MSLN</i> expressing MSS CRC. The gene discussed is MSLN; the disease is colorectal carcinoma.